ADDF launches $150M diagnostics accelerator to speed tau blood tests and AI biomarkers [developing]

ADDF DxA phase 3 $50M to $150M (Mar 2026) tau/co-path/AI FDA; Cure Alzheimer’s urgent; ADDI $1M AI. Tau Global Conf; PI-2620/C2N eMTBR/Spear/Tau Prize/ApoE/VeraBIND; BIONIC/staging/BU PreSiBO; DAC equity; TrialMatch AI platform accelerates trial matching/access.